NCT05009732 — Covid19 trial site landscape

Public-registry site landscape for NCT05009732, a Covid19 study sponsored by Suzhou Kintor Pharmaceutical Inc,. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT05009732 (registry record)
Sponsor	Suzhou Kintor Pharmaceutical Inc,
Condition(s)	Covid19
Phase	PHASE3
Listed sites	30
Site countries	United States, China, Philippines, South Africa, Ukraine

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05009732 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.